Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Patricia Martin-Romano"'
Autor:
Capucine Baldini, Francois-Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise Halse, Severine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martin-Romano, Jean-Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amelie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel-Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurelien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean-Charles Soria, Christophe Massard, Aurelien Marabelle
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-14 (2022)
Abstract Background We aimed to determine the safety and efficacy of nintedanib, an oral anti-angiogenic tyrosine kinase inhibitor, in combination with pembrolizumab, an anti-PD1 immunotherapy, in patients with advanced solid tumors (PEMBIB trial; NC
Externí odkaz:
https://doaj.org/article/cc022ab82e6e4fd69d684a17c4dfa3ff
Autor:
Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2643-2652 (2020)
Abstract Background PD(L)1 antibodies (anti‐PD(L)‐1) have been a major breakthrough in several types of cancer. Novel patterns of response and progression have been described with anti‐PD(L)‐1. We aimed at characterizing pseudoprogression (PS
Externí odkaz:
https://doaj.org/article/a4e7a1041c934bc3942c24fc39614624
Autor:
Guillaume Manson, Alexandre Thibault Jacques Maria, Florence Poizeau, François-Xavier Danlos, Marie Kostine, Solenn Brosseau, Sandrine Aspeslagh, Pauline Du Rusquec, Maxime Roger, Maud Pallix-Guyot, Marc Ruivard, Léa Dousset, Laurianne Grignou, Dimitri Psimaras, Johan Pluvy, Gilles Quéré, Franck Grados, Fanny Duval, Frederic Bourdain, Gwenola Maigne, Julie Perrin, Benoit Godbert, Beatris Irina Taifas, Alexandra Forestier, Anne-Laure Voisin, Patricia Martin-Romano, Capucine Baldini, Aurélien Marabelle, Christophe Massard, Jérôme Honnorat, Olivier Lambotte, Jean-Marie Michot
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background Paraneoplastic syndromes (PNS) are autoimmune disorders specifically associated with cancer. There are few data on anti-PD-1 or anti-PD-L1 immunotherapy in patients with a PNS. Our objective was to describe the outcome for patient
Externí odkaz:
https://doaj.org/article/ca72d3ba97984c078f0aec5f8467a55e
Autor:
Patricia Martin-Romano, Julien Adam, Jean-Yves Scoazec, Sébastien Gouy, Antonin Levy, Capucine Baldini, Stéphane Champiat, Jean-Charles Soria, Christophe Massard, Aurélien Marabelle, Eric Deutsch, Antoine Hollebecque
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Immunotherapy has dramatically changed the treatment landscape for several tumor types. However, the impact of previous radiotherapy (RT) on response to immunotherapy is still unknown. We report the case of a 58-year-old female diagnosed with a squam
Externí odkaz:
https://doaj.org/article/a9848339c5df4201aff9b1a92b7f8bfd
Autor:
Patricia Martin-Romano, Belén P Solans, David Cano, Jose Carlos Subtil, Ana Chopitea, Leire Arbea, Maria Dolores Lozano, Eduardo Castanon, Iosune Baraibar, Diego Salas, Jose Luis Hernandez-Lizoain, Iñaki F Trocóniz, Javier Rodriguez
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0215970 (2019)
BackgroundPerioperative chemotherapy (CT) or neoadjuvant chemoradiotherapy (CRT) in patients with locally advanced gastric (GC) or gastroesophageal junction cancer (GEJC) has been shown to improve survival compared to an exclusive surgical approach.
Externí odkaz:
https://doaj.org/article/62a30225fcf74be3b80b852377e674f6
Autor:
Lauren Seknazi, Arthur Geraud, Vincent Goldschmidt, Capucine Baldini, Stéphane Champiat, Christophe Massard, Sophie Postel-Vinay, Aurelien Marabelle, Rastilav Bahleda, Antoine Hollebecque, Cristina Smolenschi, Anas Gazzah, Jean-Marie Michot, Patricia Martin-Romano, Aurore Vozy, Perrine Vuagnat, François-Xavier Danlos, Arnaud Bayle, Linda Mahjoubi, Barbara Pistilli, Yohann Loriot, Santiago Ponce-Aix, Kaissa Ouali
Publikováno v:
Cancer Research. 83:P2-13
Background: Breast cancer (BC) is the most frequent cancer and the second leading cause of cancer death for women. Although there is a need of new treatments to improve BC outcome, patients with BC are still under-represented in early phase trials, p
Autor:
Jean‐Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El‐Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi‐Rouche, Patricia Martin‐Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean‐Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara‐Clayette, Vincent Ribrag
Publikováno v:
American Journal of Hematology. 98:645-657
Autor:
Patricia, Martin-Romano, Leo, Colmet-Daage, Daphne, Morel, Capucine, Baldini, Loic, Verlingue, Rastilav, Bahleda, Anas, Gazzah, Stephan, Champiat, Andree, Varga, Jean Marie, Michot, Maud, Ngo-Camus, Claudio, Nicotra, Aurelien, Marabelle, Jean Charles, Soria, Etienne, Rouleau, Ludovic, Lacroix, Antoine, Hollebecque, Christophe, Massard, Sophie, Postel-Vinay
Publikováno v:
European Journal of Cancer. 173:133-145
Although the role of epigenetic alterations in oncogenesis has been well studied, their prevalence in metastatic solid tumours is still poorly described. We therefore aimed at: (i) describing the presence of epigenetic gene alterations (EGA) - define
Autor:
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Giuseppe Curigliano, Victor Moreno, Filippo de Braud, Sonia Gonzalez de Villambrosia, Patricia Martin‐Romano, Eric Baudin, Marina Arias, Juan de Alvaro, Josep L. Parra‐Palau, Tania Sánchez‐Pérez, Ida Aronchik, Ellen H. Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S. de Bono
Publikováno v:
Scientia
Lysine-specific demethylase 1 (LSD1) inhibitor; Neuroendocrine tumor; Non-Hodgkin lymphoma Tumor neuroendocrino; Linfoma no Hodgkin; Inhibidores de desmetilasa-1 específica a lisina Tumor neuroendocrí; Limfoma no Hodgkin; Inhibidor de la desmetilas
Autor:
Johann S. de Bono, Zariana Nikolova, Manisha Lamba, Ellen H. Filvaroff, Ida Aronchik, Tania Sánchez-Pérez, Josep L. Parra-Palau, Jorge Di Martino, Juan de Alvaro, Sheila Mora, Marina Arias, Eric Baudin, Patricia Martin-Romano, Victor Moreno, Giuseppe Curigliano, Jaume Capdevila, Patricia Niccoli, Nicolas Isambert, Ruth Plummer, Stefania Salvagni, Antoine Hollebecque
Supplementary Figure S3. Platelet Count Over Time in Response to CC-90011 at the RP2D (A), MTD (B), and NTD (C). Error bars indicate range. C, cycle; D, day; MTD, maximum tolerated dose; NTD, nontolerated dose; RP2D, recommended phase 2 dose. Data cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a101996b0b632cf7b3e47d960ac7f17
https://doi.org/10.1158/1078-0432.22478382.v1
https://doi.org/10.1158/1078-0432.22478382.v1